Waldenström Macroglobulinemia

Blood Cancers

Brain Cancer

Metastatic Breast Cancer

Breast Cancer

Childhood Cancers

Anal Cancer

Colorectal Cancer

Esophageal Cancer

Gallbladder Cancer

Gastrointestinal stromal tumor

Liver Cancer

Pancreatic Cancer

Gastrointestinal Cancers

Bladder Cancer

Kidney Cancer

Prostate Cancer

Testicular Cancer

Genitourinary Cancers

Cervical Cancer

Ovarian Cancer

Uterine Cancer

Vulvar Cancer

Gynecologic Cancer

Head & Neck Cancer

Immunotherapy

Acute Myeloid Leukemia

Leukemia

Mesothelioma

Lung Cancer

Follicular Lymphoma

Mantle Cell Lymphoma

Non-Hodgkin Lymphoma

Small Lymphocytic Lymphoma (SLL)

Lymphoma

Myeloma

Cancer of Unknown Primary

Carcinoid Cancer

Neuroendocrine Cancer

Rare Cancers

Sarcoma

Melanoma

Skin Cancer

Thyroid Cancer

News

Cancer Horizons

All News

Blogs

Caregiving

Diet and Exercise

Financial

Psychosocial

Recipes

Sexual Health

Side Effect

Survivorship

Videos

All Videos

CURE Connections

CURE Expert Connections®

CURE Speaking Out

CURE TV

Educated Patient Sound Bites

On Demand: Webinars

Conferences

Conference Coverage 

Conference Listing 

Events

CURE Adventures

CURE Awards

Educated Patient In Person Education

Educated Patient Virtual Education

Resources

Advocacy Groups

Art Gallery

Clinical Trial Corner

Heal®

Partners

Podcasts

Publications

Share Your Story

Subscribe

The testicular cancer condition center is a comprehensive resource for cancer news & oncologist insights on testicular cancer. Read more about cancer at CURE.

Testicular Cancer | Oncology & Cancer News | Tumor |  CURE

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

About Us

Advertise / Support

Editorial Board

Contact Us

CancerNetwork.com

TargetedOnc.com

OncLive.com

OncNursingNews.com

Terms & Conditions

Privacy

Do Not Sell My Information

CURE - Oncology & Cancer News for Patients & Caregivers

Facebook

Youtube

Instagram

Spotlight

Breast Cancer Webinar Series

Cancer Type

Bladder

Breast

Kidney

Lung

Ovarian

Prostate

Skin

About CURE

Press Releases

Write for CURE

1rem

Tumor

CURE’s testicular cancer page features the latest cancer news and updates on testicular cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in testicular cancer.

A strong support system can make a world of difference when someone is battling cancer. Just having the right people and volunteers in someone’s corner cheering them on can elevate their spirits and help them push through their grueling treatments.

 Talks Cancer” podcast, we spoke with Brandon Stevens, a testicular cancer survivor who chronicles his experience and how those around him helped him get through his grueling chemotherapy treatments.

Stevens, who was originally diagnosed not long following his high school graduation, is now a student within the professional pilot program at Kansas State University Polytechnic Campus training for his pilot’s license.

After positive experiences with therapy dogs during his treatment, Stevens decided to use his training to become a pilot to give back to dogs in need and is volunteering for Pilots N Paws, a nonprofit organization that facilitates transportation for rescue animals and animals in need. Stevens also said he hopes to start a nonprofit of his own for children with cancer.

“I think it's just a natural psychological thing that happens and for me, I just think everyone has done so much for me and I see a lot of the good people who are going out of their way, not getting paid to help you, and they genuinely want to help and I think it's natural in us to want to do that and I can't think of better ways to give back to the community.”

In this episode of the “CURE Talks Cancer” podcast, we spoke with a testicular cancer survivor who is using his love of flying to give back to the community, including volunteering for Pilots N Paws, a nonprofit organization that assists in the transportation of rescue animals and animals in need of medical treatment.
 

A Cancer Survivor's Love of Flying Propels a Passion for Volunteering

Fifteen years ago, at the age of 31 and just married about a month prior, Scott Petinga and his wife had discovered he had stage 1 testicular cancer — a disease he was severely overtreated for.

After 16 rounds of radiation, Petinga was left with one less testicle, infertile and unable to properly produce hormones — all things that affect him still today.

As a result, Scott has become a patient advocate and philanthropic entrepreneur to help raise awareness for others by founding organizations like the TH!NK DIFFERENT Foundation, the Fairy Foundation and the Center of Advocacy for Cancer of the Testes International (CACTI).

 spoke with Petinga about his journey with testicular cancer, why getting a second opinion is key and how community can help patients and their loved ones navigate the new normal after a cancer diagnosis.  

In this episode of the “CURE Talks Cancer” podcast, we spoke with Scott Petinga, who was diagnosed with and overtreated for his stage 1 testicular cancer, about his journey and how he now advocates for other patients.

Live for Today: One Testicular Cancer Survivor's Journey to Advocacy

Receiving a cancer diagnosis can be terrifying—Olympic gold medalist Scott Hamilton knows that firsthand. However, after the shock wears off, it’s possible to use cancer as a motivation to do better in the world. That’s what Scott Hamilton did by starting the Scott Hamilton CARES foundation, which is dedicated to improving the future of cancer care.

In this week’s episode, we spoke with Hamilton about his personal bouts with testicular cancer and a brain tumor, as well as losing his mother to breast cancer. The former professional ice skater also touches upon why he wanted to be involved in CURE’s 2018 MPN Heroes event.

For this episode of the CURE Talks Cancer podcast, we spoke with Scott Hamilton, an Olympic gold medalist, cancer survivor and founder of the Scott Hamilton CARES Foundation

Scott Hamilton: When Fear Flips

Talks Cancer, we spoke with blogger, advocate and 

 contributor, Justin Birckbichler. Justin has managed to mostly steer clear of doctors' offices until a few years ago when he found a lump on his testicle, and heard the words, "you have testicular cancer."

Shocked to receive a cancer diagnosis in his mid-20s, Justin, a schoolteacher, turned to writing as an outlet to document his journey, as well as advocate for men's health. Now, he is conducting a study to see how frequently testicular health is discussed at medical appointments.

It's time we talk about men's health, says Justin Birckbichler.

Getting "Ballsy" During Men's Health Month

Maria, my oncology nurse, inspired lasting change in my life through compassion, wisdom and faith during my cancer surgery and recovery.

What I Learned From My Cancer Nurse Maria

After testicular cancer, I’ve learned to guard my mood, seek small joys and embrace healing and renewal with every sunrise this spring.

Renewal and Healing from Testicular Cancer This May 

Experiencing spring's renewal after a cancer diagnosis, I focus on health through checkups, diet and exercise, embracing change and well-being.

Springtime Health After My Testicular Cancer Diagnosis

Testicular cancer is rare but highly curable, especially with early detection; treatment varies by stage, and follow-up care supports long-term health.

Knowing the Signs to Detect and Treat Testicular Cancer Early

Hope helped me navigate my testicular cancer diagnosis at 20, shaping my resilience and guiding my journey as a survivor.

How Hope Erased My Fear of Testicular Cancer

April serves as Testicular Cancer Awareness Month, which is the most common type of cancer in men aged between 15 and 44 years old.

Early Detection Critical for Testicular Cancer in Young Men 

April is Testicular Cancer Awareness Month, according to the Testicular Cancer Awareness Foundation, and because testicular cancer is the most common type of cancer in men aged between 15 and 44 years old, it is important to help raise awareness for ways to address this disease.

It is important to note that early detection of testicular cancer is key, and with early detection, patients often have the opportunity to eliminate the need for additional surgeries, chemotherapy or radiation. The Testicular Cancer Awareness Foundation website also notes that early detection impacts financial toxicity and can, in turn, ease both financial and emotional burden on patients faced with this disease.

“Testicular cancer is scary. Cancer is scary. Cancer is a charged term. However, this is one that's highly curable,” Dr. Benjamin Garmezy emphasized in an interview with CURE.

In the interview, he discussed the importance of early intervention for the best possible outcomes in patients with this disease.

Garmezy is a medical oncologist and the assistant director of Genitourinary (FU) Research at Sarah Cannon Research Institute, as well as the co-chair of the GU Research Executive Committee at SCRI Oncology, in Nashville, Tennessee.

Testicular cancer is scary. Cancer is scary. Cancer is a charged term. However, this is one that's highly curable. We say every patient diagnosed with this disease has a chance of cure, and a highly likely chance of cure. Over 90% of these men are going to get cured. What I tell my patients is this is hopefully just going to be a bad dream in your life's rearview mirror, and we're going to get you through it. But even if that frontline chemo doesn't work, there are other options. We can do transplant. We can do higher doses of chemotherapy and still cure patients with those salvage options.

Sarah Cannon Research Institute — where I work — has a whole host of clinical trials available for patients with novel cellular therapies, where we're genetically engineering white blood cells to go into a patient and try to directly attack the tumor, or we have a molecule that will grab onto your own immune cells and bring them into the tumor, called a T-cell engager. We have all sorts of really cool technology as well that can really help, I think, extend life and perhaps achieve more cures in patients with testicular cancer. So, that's the big picture. Understand that this is scary, but also understand that there's a lot of help out there.

Transcript has been edited for clarity and conciseness.

For more news on cancer updates, research and education, don’t forget to 

Testicular Cancer

Latest News